Number of Clinical Trials 2005
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
Rank | Actions | ||
|---|---|---|---|
1 | United States | 1,724 | |
2 | Germany | 154 | |
3 | Canada | 144 | |
4 | United Kingdom | 84 | |
5 | France | 79 | |
6 | Netherlands | 58 | |
7 | Italy | 45 | |
8 | Taiwan | 44 | |
9 | Japan | 42 | |
10 | Spain | 42 | |
11 | Denmark | 40 | |
12 | Belgium | 39 | |
13 | China | 32 | |
14 | Switzerland | 31 | |
15 | Australia | 31 | |
16 | Sweden | 29 | |
17 | Brazil | 26 | |
18 | India | 26 | |
19 | Norway | 25 | |
20 | Israel | 20 | |
21 | South Korea | 17 | |
22 | Poland | 14 | |
23 | South Africa | 14 | |
24 | Thailand | 12 | |
25 | Austria | 12 | |
26 | Finland | 11 | |
27 | Russia | 11 | |
28 | Malawi | 9 | |
29 | Mexico | 9 | |
30 | Argentina | 8 | |
31 | Portugal | 8 | |
32 | Turkey | 6 | |
33 | Bangladesh | 5 | |
34 | Egypt | 5 | |
35 | New Zealand | 5 | |
36 | Singapore | 5 | |
37 | Slovakia | 5 | |
38 | Malaysia | 4 | |
39 | Tanzania | 3 | |
40 | Gambia | 3 | |
41 | Ghana | 3 | |
42 | Iran | 3 | |
43 | Jamaica | 3 | |
44 | Mozambique | 3 | |
45 | Pakistan | 3 | |
46 | Philippines | 3 | |
47 | Ukraine | 2 | |
48 | Bulgaria | 2 | |
49 | Burkina Faso | 2 | |
50 | Chile | 2 | |
51 | Greece | 2 | |
52 | Guatemala | 2 | |
53 | Haiti | 2 | |
54 | China, Hong Kong SAR | 2 | |
55 | Hungary | 2 | |
56 | Indonesia | 2 | |
57 | Ireland | 2 | |
58 | Kenya | 2 | |
59 | Saudi Arabia | 2 | |
60 | Togo | 1 | |
61 | Tunisia | 1 | |
62 | Vietnam | 1 | |
63 | Algeria | 1 | |
64 | Botswana | 1 | |
65 | Colombia | 1 | |
66 | Congo | 1 | |
67 | Croatia | 1 | |
68 | Czech Republic | 1 | |
69 | Congo, Democratic Republic of the | 1 | |
70 | Ecuador | 1 | |
71 | Ethiopia | 1 | |
72 | Honduras | 1 | |
73 | Kazakhstan | 1 | |
74 | Lebanon | 1 | |
75 | Mali | 1 | |
76 | Mauritius | 1 | |
77 | Nepal | 1 | |
78 | Puerto Rico | 1 | |
79 | Romania | 1 | |
80 | Senegal | 1 |
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #80
Senegal
- #79
Romania
- #78
Puerto Rico
- #77
Nepal
- #76
Mauritius
- #75
Mali
- #74
Lebanon
- #73
Kazakhstan
- #72
Honduras
- #71
Ethiopia
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Congo, Democratic Republic of the
In 2005, Congo, Democratic Republic of the ranked #64 globally with a total of 1 clinical trial. This figure is notably low compared to many other countries, reflecting a limited capacity for clinical research in the region. Contributing factors include a challenging healthcare infrastructure, ongoing political instability, and economic constraints that hinder investment in medical research initiatives.
Kazakhstan
In 2005, Kazakhstan ranked #70 globally with a total of 1 clinical trial. This number reflects a significant gap compared to leading countries in clinical research, indicating limited engagement in the sector. Contributing factors include Kazakhstan's developing healthcare infrastructure and a relatively small population, which may hinder the capacity for extensive clinical research initiatives.
Israel
In 2005, Israel ranked #20 globally with a total of 20 clinical trials. This number is notable as it reflects Israel's strong emphasis on medical research and innovation, particularly when compared to regional neighbors that may have fewer resources allocated to clinical studies. The country's robust technology sector, highly educated workforce, and supportive government policies foster an environment conducive to clinical research, making it a key player in the global medical landscape.
South Africa
In 2005, South Africa ranked #23 globally with a total of 14 clinical trials. This figure is relatively low compared to leading countries in clinical research, highlighting the challenges faced in the region. Factors contributing to this statistic include South Africa's diverse population, which offers a unique opportunity for clinical studies, and its established regulatory framework that supports medical research. However, limited funding and infrastructure can hinder the growth of clinical trials in the country.
China
In 2005, China ranked #13 globally with a total of 32 clinical trials. This figure is notable compared to the top-ranked United States, which had a significantly higher number of trials that year. The rapid growth of China's pharmaceutical industry, supported by government policies favoring research and development, has been a key driver in increasing clinical trial activity.
Switzerland
In 2005, Switzerland ranked #15 globally with a total of 31 clinical trials. This number is notable compared to the global average, highlighting Switzerland's strong position in the clinical research landscape. The country's robust pharmaceutical industry, characterized by major companies and a highly skilled workforce, drives significant investment in clinical trials, fostering innovation and attracting international research collaborations.
Lebanon
In 2005, Lebanon ranked #71 globally with a total of 1 clinical trial. This figure is notably low compared to many neighboring countries and reflects a broader trend of limited clinical research activity in the region. Factors contributing to this situation include ongoing political instability and a lack of substantial investment in healthcare infrastructure, which hinder the development of clinical research initiatives.
Mali
In 2005, Mali ranked #72 globally with a total of 1 clinical trial. This figure is significantly lower than many of its African neighbors, reflecting a lack of investment in healthcare research compared to countries with more developed clinical research infrastructures. Contributing factors include limited funding for medical research, a smaller population base for trial recruitment, and ongoing challenges in the healthcare system.
Ukraine
In 2005, Ukraine ranked #58 globally with a total of 2 clinical trials. This figure is notably low compared to many Western European nations, which often report significantly higher numbers. The limited number of clinical trials in Ukraine can be attributed to challenges such as underfunding in healthcare research and a lack of robust regulatory frameworks that can hinder the development of clinical research initiatives.
Malaysia
In 2005, Malaysia ranked #38 globally with a total of 4 clinical trials. This figure is relatively low compared to other countries in the region, reflecting a developing landscape for clinical research. The limited number of trials can be attributed to factors such as a smaller investment in research and development compared to more advanced nations, as well as regulatory challenges that may deter international pharmaceutical companies.
Analysis & Context
In 2005, the United States led the world with the highest Number of Clinical Trials, totaling 1724, while the global range spanned from a minimum of 1 to a maximum of 1724. The median number of clinical trials conducted globally was 3, indicating a significant concentration of trials in a few leading countries.
Concentration of Clinical Trials in Developed Nations
The distribution of clinical trials in 2005 reveals a stark concentration in developed countries, with the United States alone accounting for an overwhelming number. This concentration is indicative of several factors including robust healthcare infrastructure, significant investment in medical research, and a high number of pharmaceutical companies headquartered in these regions. Germany and Canada followed with 154 and 144 trials respectively, reflecting their strong commitment to medical innovation.
In Europe, countries like the United Kingdom and France also featured prominently with 84 and 79 trials. The presence of leading pharmaceutical companies and research institutions in these countries facilitates a high level of clinical research activity.
Limited Clinical Trials in Developing Regions
In contrast, numerous countries recorded only 1 clinical trial, including Mauritius, Tunisia, and Vietnam. This limited activity can be attributed to various challenges such as inadequate funding, lack of infrastructure, and regulatory hurdles that impede clinical research. The economic constraints and less developed healthcare systems in these regions often result in fewer opportunities for conducting clinical trials.
Moreover, the absence of major pharmaceutical companies in these countries further limits their capacity to initiate and sustain clinical research projects. As a result, these nations tend to rely on external collaborations or support to partake in global clinical research efforts.
Year-over-Year Growth and Decline
The year-over-year changes in the number of clinical trials highlight significant growth and some declines. The United States saw an increase of +562 trials, a 48.4% rise, underscoring its expanding research capabilities and investment. Similarly, Germany and France experienced substantial increases of +83 and +43 trials, reflecting their strategic emphasis on growing their research sectors.
Conversely, countries like Gambia and Pakistan experienced declines of -3 and -2 trials, respectively. These decreases might be attributed to economic or political instability, which can disrupt ongoing research projects and deter new ones.
Implications for Global Health Research
The disparities in the number of clinical trials conducted globally have significant implications for health research and access to new treatments. Countries with a higher number of trials, like the United States and Germany, are likely to lead in medical breakthroughs and have quicker access to new therapies. This can contribute to better health outcomes and more advanced healthcare systems.
In contrast, the limited clinical trial activity in developing countries may restrict access to cutting-edge treatments and hinder the development of region-specific medical solutions. Addressing these disparities requires international cooperation and investment to build research infrastructure and capacities in underrepresented regions.
Overall, the data from 2005 underscores the need for a more equitable distribution of clinical research activities to ensure that all regions can benefit from advancements in medical science.
Frequently Asked Questions About Number of Clinical Trials in 2005
Which country conducted the most clinical trials in 2005?
The United States conducted the most clinical trials in 2005, with a total of 1,724 trials.
What is the average number of clinical trials conducted by countries in 2005?
The average number of clinical trials conducted by countries in 2005 was 36.83.
Which country had the fewest clinical trials in 2005?
Mauritius had the fewest clinical trials in 2005, with only 1 trial conducted.
What is the median number of clinical trials conducted by countries in 2005?
The median number of clinical trials conducted by countries in 2005 was 3.
How many countries conducted only 1 clinical trial in 2005?
There were 10 countries that conducted only 1 clinical trial in 2005.
What is the range of clinical trials conducted by countries in 2005?
The range of clinical trials conducted by countries in 2005 spans from 1 trial in Mauritius to 1,724 trials in the United States.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2005. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2005
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.